Mechanism of Action: How GLP-1 Agonists Work GLP-1 agonists work by activating GLP-1 receptors in the body
If patients receive GLP1 medications outside their primary health system (for example, from telehealth) or change providers during the treatment, the EHR data collected in our study may not capture the full course of treatment, and this may explain our observation of generally shorter treatment durations, and hence less weight loss, recorded in EHRs
Localization of a Feeding Center in the Hypothalamus of the Rat
21 Pharmacists should also counsel patients on the importance of maintaining adequate hydration, especially in the presence of vomiting or diarrhea, to prevent dehydration and reduce the risk of acute kidney injury
An Q, Zou H
Retatrutide is the research name for LY3437943, an investigational peptide designed as a single molecule with agonist activity at three receptor systems: GIP, GLP-1, and glucagon